Literature DB >> 26244325

PML in Patients Treated with Dimethyl Fumarate.

Deepak Balak, Enes Hajdarbegovic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26244325     DOI： 10.1056/NEJMc1506151

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Secondary Immunodeficiency and Risk of Infection Following Immune Therapies in Neurology.

Authors:  Fabian Szepanowski; Clemens Warnke; Gerd Meyer Zu Hörste; Anne K Mausberg; Hans-Peter Hartung; Christoph Kleinschnitz; Mark Stettner
Journal:  CNS Drugs       Date:  2021-10-16       Impact factor: 5.749

2.  Disseminated zoster with paresis in a multiple sclerosis patient treated with dimethyl fumarate.

Authors:  Brandy B Ma; Lyle W Ostrow; Scott D Newsome
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-03-09

3.  Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway.

Authors:  Guangrui Li; Ryo Yamasaki; Mei Fang; Katsuhisa Masaki; Hirofumi Ochi; Takuya Matsushita; Jun-Ichi Kira
Journal:  Sci Rep       Date:  2018-01-31       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.